Overview

Effects of Linagliptin on Active GLP-1 Concentrations in Subjects With Renal Impairment

Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
This is a bi-centric, prospective, open study comparing the effects of linagliptin on active GLP-1 concentrations in subjects with renal impairment compared to subjects with normal renal function.
Phase:
Phase 4
Details
Lead Sponsor:
Profil Institut für Stoffwechselforschung GmbH
Treatments:
Linagliptin